XDx Receives $12,500,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c3205c99-c086-452e-aca0-27eec6da5f0a&Preview=1 -
Date
1/28/2011 -
Company Name
XDx -
Mailing Address
3260 Bayshore Blvd Brisbane, CA 94005 -
Company Description
XDx is a molecular diagnostics company, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project. -
Website
http://www.xdx.com -
Transaction Type
Debt -
Transaction Amount
$12,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The financing provides the company with working capital to expand the commercialization of its FDA-cleared, innovative, non-invasive AlloMap® molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases, including lupus. -
M&A Terms
-
Venture Investor
GE Healthare Financial Services
